TSHA Financials
Taysha Gene Therapies Inc - Financial statements & key metrics
Stock Price
$5.71
Market Cap
$640.75M
P/E Ratio
-15.9
EPS
$-0.36
Income Statement Highlights
Most Recent Quarter: 2024-12-31
Revenue
$8.33M
Gross Profit
-
Operating Income
-
Net Income
$-89.30M
EPS (Diluted)
$-0.36
Balance Sheet Highlights
Total Assets
$160.36M
Total Liabilities
$88.84M
Shareholders Equity
-
Cash & Equivalents
$139.04M
Total Debt
-
Cash Flow Highlights
Operating Cash Flow
$-81.22M
CapEx
-
Free Cash Flow
-
Profitability Metrics
Net Margin
-1071.6%
View Complete Financial Statements
Full income statements, balance sheets, and cash flows for multiple periods
Open Full FinancialsFrequently Asked Questions
What is TSHA revenue?
TSHA's most recent quarterly revenue was $8.33M. Annual revenue can be calculated by summing the four most recent quarters.
Is TSHA profitable?
TSHA reported a loss of $89.30M in the most recent quarter. The net profit margin is -1071.6%.
What is TSHA market cap?
TSHA has a market capitalization of $640.75M, making it a small-cap stock.
Does TSHA have debt?
View TSHA's balance sheet for debt information.
What is TSHA cash flow?
Cash flow data is available in the full financial statements.